A Clinical Endpoint Bioequivalence Study to Assess Efficacy and Safety of Ivermectin 0.5% Lotion in the Treatment of Head Lice
Condition: Head Lice Interventions: Drug: Ivermectin 0.5% Topical Application Lotion; Drug: Ivermectin 0.5% Topical Application Lotion [SKLICE]; Drug: Placebo 0% Lotion Sponsor: bioRASI, LLC Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials